Stocks
165649NXY
YHDHealthcareBiotechnology
A specialty pharmaceutical company focused on developing and commercializing therapies for central nervous system disorders. Its lead product targets a niche neurological condition, and the company has attracted investor attention due to its clinical pipeline and potential market opportunity. Revenue is minimal, with valuation tied to regulatory milestones and commercial execution.
Congressional Interest in 165649 (NXY)
3 members of Congress have disclosed 15 trades in 165649 (NXY), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 7 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
15
Unique Politicians
3
Buys
8
Sells
7
Who in Congress Is Trading NXY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-10-07 | KENNY MARCHANT | buy | $1K-$15K |
| 2009-10-12 | LEE TERRY | sell | $1K-$15K |
| 2008-09-05 | MICHAEL T. MCCAUL | buy | — |
| 2008-09-05 | MICHAEL T. MCCAUL | sell | — |
| 2008-09-05 | MICHAEL T. MCCAUL | sell | — |
| 2008-05-09 | MICHAEL T. MCCAUL | buy | — |
| 2008-05-09 | MICHAEL T. MCCAUL | sell | — |
| 2008-05-09 | MICHAEL T. MCCAUL | sell | — |
| 2008-03-01 | MICHAEL T. MCCAUL | buy | — |
| 2008-03-01 | MICHAEL T. MCCAUL | sell | — |
| 2008-03-01 | MICHAEL T. MCCAUL | sell | — |
| 2007-05-09 | MICHAEL T. MCCAUL | buy | $125,953.65 |
| 2007-05-09 | MICHAEL T. MCCAUL | buy | (125,953.65) |
| 2007-02-11 | MICHAEL T. MCCAUL | buy | $10,150.50 |
| 2007-02-11 | MICHAEL T. MCCAUL | buy | (10,150.50) |